INSA yields 0.06% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 4
Combined, INSA + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of INSA + JNJ for your $10,000?
Uniroyal Global Engineered Products, Inc. develops, manufactures, and distributes vinyl coated fabrics used in transportation, residential, hospitality, health care, office furniture, and automotive applications. Its products in the automotive industry are used primarily in seating, door panels, head and arm rests, security shades, and trim components. The company's non-automotive applications include outdoor seating for utility and sports vehicles; and sheeting used in medical and toxic hazard protection, personal protection, moisture barriers, stroller and nursery equipment, and decorative surface applications. It also manufactures textured coatings and polymer films. The company offers its products primarily under the Naugahyde, BeautyGard, Flameblocker, Spirit Millennium, Ambla, Amblon, Velbex, Cirroflex, Plastolene, and Vynide brands. It provides its products through sales persons, agents, and distributors in North America, Europe, Asia, and internationally. Uniroyal Global Engineered Products, Inc. was founded in 1992 and is based in Sarasota, Florida.
Full INSA Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.